Skip to content

Changes in CapMan Plc’s management group


CapMan Stock Exchange Release 3 April 2009 12.45 p.m. 

Head of CapMan Life Science, Senior Partner Jan Lundahl, B. Sc. (Econ.) resigns from CapMan and leaves CapMan Plc’s management group. Deputy Head of CapMan Life Science, Partner Johan Bennarsten, M.Sc. (Eng.), M.D., has been appointed as Head of CapMan Life Science starting from 6 April 2009. Johan Bennarsten will report to CEO Heikki Westerlund.
CapMan Life Science is one of CapMan’s six investment areas. The capital in CapMan’s life science funds totaled EUR 88 million at the end of 2008, and the funds have 12 portfolio companies. The capital managed by CapMan totals EUR 3.4 billion and CapMan funds have altogether over 60 companies and nearly 60 real estate targets in their portfolios.
For more information, please contact:
Heikki Westerlund, CEO, CapMan Plc, tel.  +358 207 206 504 or +358 50 599 6580
Mari Reponen
Communications Director
Investor Services
Helsinki Stock Exchange
Principal media
CapMan is one of the leading alternative asset managers in the Nordic countries and Russia and manages private equity funds with approximately EUR 3.4 billion in total capital. CapMan has six investment areas (CapMan Buyout, CapMan Technology, CapMan Life Science, CapMan Russia, CapMan Public Market and CapMan Real Estate), and each of them has a dedicated team and funds. Altogether CapMan employs over 140 people in Helsinki, Stockholm, Copenhagen, Oslo and Moscow. CapMan was established in 1989 and its B shares are listed on the Helsinki Stock Exchange since 2001.